Everest, CR Pharma sign MoU to launch company for mRNA vaccines
Everest Medicines has signed a MoU for a collaboration with CR Pharma to set up a company focused on mRNA vaccine development.
Stay updated with breaking news from Wei Fu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Everest Medicines has signed a MoU for a collaboration with CR Pharma to set up a company focused on mRNA vaccine development.
/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing...
/PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired a portfolio of five prescription pharmaceutical...
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Press release content from PR Newswire. The AP news staff was not involved in its creation.